GI Dynamics says it can restart sales of its EndoBarrier weight loss device in Europe, having resolved concerns over use guidelines and how it reports adverse events.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yBJacq
Cap comentari:
Publica un comentari a l'entrada